142 related articles for article (PubMed ID: 31337527)
1. Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study.
Bhatt A; Yonemura Y; Benzerdjeb N; Mehta S; Mishra S; Parikh L; Kammar P; Shah MY; Prabhu A; Shaikh S; Patel MD; Isaac S; Glehen O
Eur J Surg Oncol; 2019 Dec; 45(12):2398-2404. PubMed ID: 31337527
[TBL] [Abstract][Full Text] [Related]
2. Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications.
Bhatt A; Bakrin N; Gertych W; Kammar P; Parikh L; Sheth S; Shaikh S; Devouassoux-Shisheboran M; Glehen O
Eur J Surg Oncol; 2020 Dec; 46(12):2276-2282. PubMed ID: 32600895
[TBL] [Abstract][Full Text] [Related]
3. Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction.
Bhatt A; Glehen O
Ann Surg Oncol; 2020 May; 27(5):1458-1470. PubMed ID: 31965374
[TBL] [Abstract][Full Text] [Related]
4. Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study.
Bhatt A; Rousset P; Baratti D; Biacchi D; Benzerdjeb N; H J T de Hingh I; Deraco M; Gushchin V; Kammar P; Labow D; Levine E; Moran B; Mohamed F; Morris D; Mehta S; Nissan A; Alyami M; Adileh M; Barat S; Ben Yacov A; Campbell K; Cummins-Perry K; Cortes-Guiral D; Cohen N; Parikh L; Alammari S; Bashanfer G; Alshukami A; Kundalia K; Goswami G; de Vlasakker VV; Sittig M; Sammartino P; Sardi A; Villeneuve L; Turaga K; Yonemura Y; Glehen O
BMJ Open; 2021 Jul; 11(7):e046819. PubMed ID: 34226220
[TBL] [Abstract][Full Text] [Related]
5. Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO).
Bhatt A; Sinukumar S; Mehta S; Damodaran D; Zaveri S; Kammar P; Mishra S; Parikh L; Ranade R; Penumadu P; Rajan F
Eur J Surg Oncol; 2019 Apr; 45(4):666-671. PubMed ID: 30661922
[TBL] [Abstract][Full Text] [Related]
6. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
8. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
9. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
[TBL] [Abstract][Full Text] [Related]
10. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
11. Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
Bhatt A; Yonemura Y; Mehta S; Benzerdjeb N; Kammar P; Parikh L; Shah MY; Shaikh S; Prabhu A; Mishra S; Sinukumar S; Kepenekian V; Bakrin N; Passot G; Glehen O
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):582-589. PubMed ID: 31757660
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
[TBL] [Abstract][Full Text] [Related]
14. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
[TBL] [Abstract][Full Text] [Related]
15. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982
[TBL] [Abstract][Full Text] [Related]
16. Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index.
Bhatt A; Rousset P; Benzerdjeb N; Kammar P; Mehta S; Parikh L; Goswami G; Shaikh S; Kepenekian V; Passot G; Glehen O
Colorectal Dis; 2020 Dec; 22(12):2123-2132. PubMed ID: 32940414
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Berger Y; Jacoby H; Kaufmann MI; Ben-Yaacov A; Westreich G; Sharon I; Barda L; Sharif N; Nadler R; Horesh N; Nissan A; Gutman M; Hoffman A
Ann Surg Oncol; 2019 Apr; 26(4):1103-1109. PubMed ID: 30746598
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
Hallam S; Tyler R; Price M; Beggs A; Youssef H
BJS Open; 2019 Oct; 3(5):585-594. PubMed ID: 31592510
[TBL] [Abstract][Full Text] [Related]
19. Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.
Simkens GA; van Oudheusden TR; Nieboer D; Steyerberg EW; Rutten HJ; Luyer MD; Nienhuijs SW; de Hingh IH
Ann Surg Oncol; 2016 Dec; 23(13):4214-4221. PubMed ID: 27027308
[TBL] [Abstract][Full Text] [Related]
20. Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications.
Bhatt A; Bakrin N; Kammar P; Mehta S; Sinukumar S; Parikh L; Shaikh S; Mishra S; Mallaya M; Kepenekian V; Benzerdjeb N; Glehen O
Eur J Surg Oncol; 2021 Jan; 47(1):181-187. PubMed ID: 33071172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]